CDC42 and neoplasm: We and others published several prior studies on the effect of FL-BG on reducing tumor cell motility [5, 17, 24–26, 49] primarily via Cdc42, and interactions with β-arrestin2 [49, 58], and the potential influence of GAG chains [50, 54].